URGN

NASDAQ · Equity

UroGen Pharma Ltd

US Healthcare Biotechnology

Latest week
29 May 2026
Close
28.130000
Fair value
15.640865
Expectation
Undecided 47.29%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
28.13
12-Week Change
52.55%
Trend Signal
Active
Expectation
Undecided 47.29%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
15.07
Market Dynamics
1.06

Over the latest 12 completed weeks ending 2026-05-29, URGN rose 52.55%, moving from 18.44 to 28.13. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 15.07 and has improved across the 12-week window. Market Dynamics is 1.06 on the latest week. Expectation is undecided at 47.29%.